Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-07

FDA Approved: ORKAMBI — Original Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

The FDA approved ORKAMBI (lumacaftor and ivacaftor) under an original application for the treatment of cystic fibrosis. This marks the first approval of this CF…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORKAMBI (lumacaftor and ivacaftor)

Snippet

ORIG AP for ORKAMBI (LUMACAFTOR AND IVACAFTOR)